|
|
Tackling Migraine Head On: The Role of Gepants in Migraine Treatment and Prevention
Target Audience
This activity has been designed to meet the educational needs of neurologists, primary care physicians, and advanced practice providers in neurology and primary care.
Program Overview
Advances in the understanding of the pathogenesis of migraine have led to the approval of new pharmacologic classes addressing the role of calcitonin gene-related peptide (CGRP), such as gepants. With the evolving migraine therapeutic landscape, it is important for clinicians to be up to date... |
|
|
Advancing the Care of Patients With Type 2 Diabetes and Chronic Kidney Disease: Role of the Glucagon-Like Peptide-1 Receptor Agonists: Clinical Compendium
The care of patients with type 2 diabetes and chronic kidney disease requires a multidisciplinary approach; hence, this activity takes a multidisciplinary approach to educate clinicians of various disciplines. Nephrologist and clinical trialist George Bakris, MD, reviews the burden of diabetic kidney disease (DKD) and provides guideline recommendations to properly screen and prevent cardiovascular disease events in patients with DKD. Fellow clinical trialist and diabetes expert John Buse, MD, ... |
|
|
Pathways for Optimal Sequencing, Rapid Initiation, and Titration of Therapy in Patients with Heart Failure
Many patients with heart failure (HF) do not receive foundational treatment although these therapies reduce morbidity and mortality risks. The initiation and optimization of guideline-directed medical therapies (GDMT) can be challenging, but clinical practice guidelines and algorithms are available to assist.
Navigate through this interactive self-directed CME activity to apply the most recent clinical trial data and guidance to patient-specific factors seen in real-world practice. Expert p... |
|
|
Multidisciplinary Strategies to Prevent Hospitalization in Patients with Worsening Heart Failure
Despite guideline-directed medical therapy, many patients with heart failure (HF) with reduced ejection fraction continue to experience worsening HF and hospitalizations. As such, it is incumbent upon clinicians to improve familiarity and competence with available therapies and clinical trial data that may guide patient selection to individualize and optimize therapy for patients with HF. In this interactive infographic, clinicians can access real-world strategies and expert insights to improv... |
|